NEW YORK (GenomeWeb) – The National Institutes of Health announced that it will commit $3.5 million to fund research identifying and developing biomarkers for Lewy body dementias (LBDs).

LBDs comprise two related neurodegenerative disorders characterized by the abnormal accumulation of alpha-synuclein in the brain — dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD). The conditions primarily differ in the timing of the onset of cognitive and movement symptoms. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The US National Institutes of Health has developed guidelines to gauge whether frail chimpanzees are healthy enough to be moved to a retirement sanctuary.

Osamu Shimomura, who won the 2008 Nobel Prize in Chemistry for his work on green fluorescent protein, has died.

In PLOS this week: analytical approach for finding new genetic associations, analysis of Streptococcus pyogenes-infecting viruses, and more.

Stat News reports that the head of IBM Watson Health is leaving her post.